Ahmad Mohammad Abdel-Mawgoud

Ahmad Mohammad Abdel-Mawgoud

Auto-generated profile, based on publicly available information

Ahmad Mohammad Abdel-Mawgoud

Laval University Faculty of Science and Engineering

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2010 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
AAAhmad Mohammad Abdel-Mawgoud
Ahmad Mohammad Abdel-Mawgoud
FLFrançois Lépine
François Lépine
Eric DézielEric Déziel
Eric Déziel
Rhamnolipids are glycolipidic biosurfactants produced by various bacterial species. They were initially found as exoproducts of the opportunistic pathogen Pseudomonas aeruginosa and described as a mixture of four congeners: α-L-rhamnopyranosyl-α-L-rhamnopyranosyl-β-hydroxydecanoyl-β-hydroxydecanoate (Rha-Rha-C10-C10), α-L-rhamnopyranosyl-α-L-rhamnopyranosyl-β-hydroxydecanoate (Rha-Rha-C10), as well as their mono-rhamnolipid congeners Rha-C10-C10 and Rha-C10. The development of more sensitive analytical techniques has lead to the further discovery of a wide diversity of rhamnolipid congeners and homologues (about 60) that are produced at different concentrations by various Pseudomonas species and by bacteria belonging to other families, classes, or even phyla. For example, various Burkholderia species have been shown to produce rhamnolipids that have longer alkyl chains than those produced by P. aeruginosa. In P. aeruginosa, three genes, carried on two distinct operons, code for the enzymes responsible for the final steps of rhamnolipid synthesis: one operon carries the rhlAB genes and the other rhlC. Genes highly similar to rhlA, rhlB, and rhlC have also been found in various Burkholderia species but grouped within one putative operon, and they have been shown to be required for rhamnolipid production as well. The exact physiological function of these secondary metabolites is still unclear. Most identified activities are derived from the surface activity, wetting ability, detergency, and other amphipathic-related properties of these molecules. Indeed, rhamnolipids promote the uptake and biodegradation of poorly soluble substrates, act as immune modulators and virulence factors, have antimicrobial activities, and are involved in surface motility and in bacterial biofilm development.

25 April 2008 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
AAAhmad Mohammad Abdel-Mawgoud
Ahmad Mohammad Abdel-Mawgoud
MAMohammad Mabrouk Aboulwafa
Mohammad Mabrouk Aboulwafa
NHNadia Abdel-Haleem Hassouna
Nadia Abdel-Haleem Hassouna

29 February 2008 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
AAA. Mohammad Abdel-Mawgoud
A. Mohammad Abdel-Mawgoud
MAMohammad Mabrouk Aboulwafa
Mohammad Mabrouk Aboulwafa
NHNadia Abdel-Haleem Hassouna
Nadia Abdel-Haleem Hassouna

1 January 2014 in Chemistry & Biology
Verified
Journal Article
Closed access
AAAhmad Mohammad Abdel-Mawgoud
Ahmad Mohammad Abdel-Mawgoud
FLFrançois Lépine
François Lépine
Eric DézielEric Déziel
Eric Déziel

27 June 2008 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
AAAhmad Mohammad Abdel-Mawgoud
Ahmad Mohammad Abdel-Mawgoud
MAMohammad Mabrouk Aboulwafa
Mohammad Mabrouk Aboulwafa
NHNadia Abdel-Haleem Hassouna
Nadia Abdel-Haleem Hassouna

1 March 2018 in Synthetic and Systems Biotechnology
Verified
Journal Article
Open access
AAAhmad Mohammad Abdel-Mawgoud
Ahmad Mohammad Abdel-Mawgoud
Gregory StephanopoulosGregory Stephanopoulos
Gregory Stephanopoulos
Glycosylated lipids (GLs) are added-value lipid derivatives of great potential. Besides their interesting surface activities that qualify many of them to act as excellent ecological detergents, they have diverse biological activities with promising biomedical and cosmeceutical applications. Glycolipids, especially those of microbial origin, have interesting antimicrobial, anticancer, antiparasitic as well as immunomodulatory activities. Nonetheless, GLs are hardly accessing the market because of their high cost of production. We believe that experience of metabolic engineering (ME) of microbial lipids for biofuel production can now be harnessed towards a successful synthesis of microbial GLs for biomedical and other applications. This review presents chemical groups of bacterial and fungal GLs, their biological activities, their general biosynthetic pathways and an insight on ME strategies for their production.